Puma Biotechnology Releases Slides to be Presented at #JPM20

 Puma Biotechnology Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that its Chief Executive Officer and President, Alan H. Auerbach, will be presenting at the 38^th Annual J.P. Morgan Healthcare Conference at 12:00 p.m. PST on Wednesday, January 15, 2020. Mr. Auerbach will be providing a corporate update that will include, among other things, the company’s preliminary estimate that it sold approximately 4,900 bottles of NERLYNX in the United States in the fourth quarter of 2019. This preliminary estimate is subject to completion of the Company’s customary closing and review procedures and could change based on that process. The slides to be discussed during the presentation are currently available on the Investors section of Puma’s website at https://investor.pumabiotechnology.com/sec-filings/all-filings/default.aspx. A live webcast of the presentation will also be available on January 15, 2020, at www.pumabiotechnology.com.

https://www.biospace.com/article/releases/puma-biotechnology-releases-slides-to-be-presented-at-the-j-p-morgan-healthcare-conference/